| Literature DB >> 35560197 |
Frédéric Domergue1, Magdalena Miklaszewska2,3.
Abstract
Wax esters are high-value compounds used as feedstocks for the production of lubricants, pharmaceuticals, and cosmetics. Currently, they are produced mostly from fossil reserves using chemical synthesis, but this cannot meet increasing demand and has a negative environmental impact. Natural wax esters are also obtained from Simmondsia chinensis (jojoba) but comparably in very low amounts and expensively. Therefore, metabolic engineering of plants, especially of the seed storage lipid metabolism of oil crops, represents an attractive strategy for renewable, sustainable, and environmentally friendly production of wax esters tailored to industrial applications. Utilization of wax ester-synthesizing enzymes with defined specificities and modulation of the acyl-CoA pools by various genetic engineering approaches can lead to obtaining wax esters with desired compositions and properties. However, obtaining high amounts of wax esters is still challenging due to their negative impact on seed germination and yield. In this review, we describe recent progress in establishing non-food-plant platforms for wax ester production and discuss their advantages and limitations as well as future prospects.Entities:
Keywords: Fatty acyl reductase; green factory; lubricant; oilseed crops; plant metabolic engineering; wax esters; wax synthase
Mesh:
Substances:
Year: 2022 PMID: 35560197 PMCID: PMC9113324 DOI: 10.1093/jxb/erac046
Source DB: PubMed Journal: J Exp Bot ISSN: 0022-0957 Impact factor: 7.298
Fig. 1.Wax ester production methods and industrial applications. Wax esters are important industrial lipids used as ingredients for the formulation of lubricants, cosmetics, pharmaceuticals, paints, emulsions, and printing inks. They can be produced by chemical synthesis or lipase-catalysed esterification of petroleum products or plant oils. Nowadays, natural wax esters are mainly obtained from jojoba oil, carnauba wax and beeswax.
Fig. 2.Wax ester biosynthesis. The wax ester biosynthetic pathway involves two steps. First, NAD(P)H-dependent reduction of an acyl-CoA/ACP to the corresponding alcohol is catalysed by a fatty acyl-CoA reductase (FAR). Next, a wax synthase (WS) esterifies an acyl-CoA/ACP with a fatty alcohol to produce a wax ester. Free coenzyme A (CoA) or acyl carrier protein (ACP) is released in both reactions.
Summary of modified plant species, enzyme combinations, wax ester yields, and composition
| Plant species | Enzyme combinations used | Wax ester content | Predominant wax esters | Reference |
|---|---|---|---|---|
|
| MmFAR1 + MmWS | 22 mg g−1 seed | 20:1–18:2 (16 mol%) |
|
| Oleo3-MmFAR1 + Oleo3-MmWS | 45 mg g−1 seed | 20:1–18:2 (13 mol%) | ||
|
| MaFAR + ScWS | 70 mg g−1 seed | 18:1–20:1 (13.7 mol%) |
|
|
| Oleo3-MmFAR1 + Oleo3-MmWS | 33 mg g−1 seed (17% of the oil | 16:0–18:2 (14.5 mol%) |
|
| Oleo3-MmFAR1 + ScWS | 21 mg g−1 seed (10% of the oil) | 18:1–20:1 (22.6 mol%) | ||
| MaFAR + ScWS | 108 mg g−1 seed (49% of the oil) | 18:1–20:1 (17.7 mol%) | ||
|
| Oleo3-MmFAR1 + Oleo3-MmWS | 12 mg g−1 seed (6% of the oil) | 16:0–18:2 (14.6 mol%) |
|
| Oleo3-MmFAR1 + ScWS | 21 mg g−1 seed (9% of the oil) | 18:1–20:1 (15.7 mol%) | ||
| MaFAR + ScWS | 47 mg g−1 seed (21% of the oil) | 18:1–20:1 (16.3 mol%) | ||
|
| MaFAR + ScWS | 95 mg g−1 seed (41% of the oil) | WEs containing 18:1-OH (40 mol%), 20:1-OH (20 mol%), and 20:1-FA (38 mol%) |
|
| ScWS-MaFAR fusion protein | 23 mg g−1 seed (13% of the oil) | WEs containing 20:1-OH (45–52 mol%), 18:1-OH (20–28 mol%), and 20:1-FA (40 mol%) | ||
| MaFAR + TM-AbWS/DGAT | 17 mg g−1 seed (7% of the oil) | WEs containing 18:1-OH (50 mol%), 18:2-OH (30 mol%) and 18:0-FA (40 mol%), 18:1-FA (30 mol%) | ||
| MaFAR + MaWS2 | 14 mg g−1 seed (6% of the oil) | WEs containing 18:1-OH (60 mol%), 18:2-OH (20 mol%) and 18:0-FA (60 mol%), 18:1-FA (20 mol%) | ||
| MaFAR + AbWS/DGAT | 4 mg g−1 seed (3% of the oil) | 20:1–18:1 (16 mol%) | ||
|
| MaFAR + MaWS2 | 22 mg g−1 seed (8% of the oil) | 20:1–20:1 (12 mol%) |
|
| tpMaFAR + tpMaWS2 | 12 mg g−1 seed (4% of the oil) | 18:0–18:0 (16 mol%) | ||
| MaFAR + MaWS5 | 19 mg g−1 seed (7% of the oil) | 20:1–18:1 (10 mol%) | ||
| tpMaFAR + tpMaWS5 | 12 mg g−1 seed (7% of the oil) | 18:0–18:2 (9 mol%) | ||
|
| Oleo3-MmFAR1 + Oleo3-MmWS | 17–18 mg g−1 seed (8% of the oil) | 18:1–18:1 (65 mol%) |
|
| Oleo3-MmFAR1 + ScWS | 22 mg g−1 seed (16% of the oil) | 18:1–18:1 (54 mol%) | ||
| MaFAR + ScWS | 86 mg g−1 seed (42% of the oil) | 18:1–18:1 (61 mol%) | ||
| MaFAR + AbWS/DGAT | 5 mg g−1 seed | 18:1–18:1 (62 mol%) | ||
|
| MaFAR + ScWS | 44 mg g−1 seed (20% of the oil) | 18:1–18:1 (34 mol%) |
|
|
| MaFAR + MhWS2 | 48.3 nmol/seed (29 mg g−1 seed) | WEs containing C18 (47 mol%), C20 (28 mol%), C22 (10 mol%), C16 (6 mol%) acyl moieties, and C20 (61 mol%) and C18 (30 mol%) alcohol moieties |
|
| MaFAR + MhWS2 + Thio10 | 43.5 nmol/seed (23 mg g−1 seed) | WEs with slightly reduced C18–C24 acyl moieties and slightly increased ≤C14 and C16 acyl moieties compared with | ||
| MaFAR + MhWS2 + Thio14 | 34.0 nmol/seed (18 mg g−1 seed); 67.4 nmol/seed (42 mg g−1 seed) for T3 | WEs containing C18 (34%), C20 (22%), C16 (18.6%) and ≤C14 (13.3%) acyl-moieties, and C20 (50 mol%), C18 (30 mol%) and C16 (16%) alcohol moieties | ||
| MaFAR + MmWS | 27.1 nmol/seed (10 mg g−1 seed) | All MmWS combinations: WEs containing C18 (78–80 mol%), C20 (10–12 mol%), and C16 (5–8 mol%) acyl moieties, and C20 (60–70 mol%) and C18 (25–30 mol%) alcohol moieties | ||
|
| ScFAR + ScWS | 90 mg g−1 seed (23% of the oil) | 22:1–20:1 (28 mol%) |
|
| ScFAR + ScWS + ScFAE1 | 55 mg g−1 seed (17% of the oil) | 22:1–20:1 (18 mol%) | ||
|
| ScFAR + ScWS | 50 mg g−1 seed (24% of the oil) | 22:1–22:1 (33 mol%) |
|
| ScFAR + ScWS + ScFAE1 | 48 mg g−1 seed (24% of the oil) | 24:1–24:1 (18 mol%) | ||
|
| ScFAR + ScWS | 48 mg g−1 seed (25% of the oil) | 24:0–20:1 (12 mol%) |
|
| ScFAR + ScWS + LaFAE1 | 52 mg g−1 seed (28% of the oil) | 24:1–24:1 (21 mol%) | ||
| ScFAR + ScWS + LaFAE1 + | 60 mg g−1 seed (32% of the oil) | 22:1–20:1 (25 mol%) | ||
|
| ScFAR + ScWS | Up to 44.7 mg g−1 seed | 22:1–20:1 (22.5 mol%) |
|
| ScFAR + ScWS + ScFAE1 | Up to 85.8 mg g−1 seed | 22:1–20:1 (16.2 mol%) | ||
|
| tpMaFAR + AtPES2 | 1.62 nmol mg−1 leaf FW | WEs containing 12:0 (45 mol%) and 14:0 (35 mol%) acyl moieties, and 16:0 (75 mol%) and 18:0 (25 mol%) alcohol moieties |
|
| AtFAR6 + AtPES2 | 0.9 nmol mg−1 leaf FW | WEs containing 12:0 (45 mol%) and 14:0 (35 mol%) acyl moieties, and 16:0 (90 mol%) and 18:0 (10 mol%) alcohol moieties | ||
| tpMaFAR::MhWS | 0.4 nmol mg−1 leaf FW | WEs containing 16:0 (55 mol%) and 18:0 (20 mol%) acyl moieties, and 16:0 (60 mol%) and 18:0 (35 mol%) alcohol moieties | ||
|
| tpMaFAR::MhWS | 0.28 µmol g−1 leaf FW or stem FW (0.15% DW) | WEs containing 16:0 (27 mol%), 18:0 (17 mol%), 20:0 (21%) and 22:0 (19%) acyl moieties, and 16:0 (55 mol%) and 18:0 (40 mol%) alcohol moieties |
|
For Iven and Yu , the best performing transgenic lines were listed.
Relative WE content in the total seed oil.
Due to significant variations in seed weight, the authors emphasized that quantity of WE per seed better illustrated the enzyme activities than WE quantity per g of seeds (Ruiz-Lopez ); however, the latter values were included in the table for comparison with the other studies.
Abbreviations: AbWS/DGAT, bifunctional WS/DGAT from Acinetobacter baylyi; AtFAR6, fatty acyl reductase 6 from Arabidopsis thaliana; AtPES2, phytyl ester synthase 2 from Arabidopsis thaliana; CsFAD2-RNAi, RNAi construct for silencing Camelina sativa fatty acid desaturase 2 gene; DW, dry weight; FW, fresh weight; HEA, high erucic acid; HO, high oleate; LaFAE1, 3-ketoacyl-CoA synthase from Lunaria annua; MaFAR, fatty acyl reductase from Marinobacter aquaeolei; MaWS2, wax synthase 2 from Marinobacter aquaeolei; MaWS5, wax synthase 5 from Marinobacter aquaeolei; MhWS2, wax synthase 2 from Marinobacter hydrocarbonoclasticus; Oleo3-MmFAR1, fatty acyl reductase 1 from Mus musculus fused with Oleo3 and lacking peroxisome-targeting C-terminal sequence; Oleo3-MmWS, wax synthase from Mus musculus fused with Oleo3; ScFAR, fatty acyl reductase from Simmondsia chinensis; ScFAE1, 3-ketoacyl-CoA synthase from Simmondsia chinensis; ScWS, wax synthase for Simmondsia chinensis; Thio10, 10:0-ACP thioesterase from Cuphea hookeriana; Thio12, 12:0-ACP thioesterase from Umbellularia californica; Thio14, 14:0-ACP thioesterase from Cuphea palustris; TM-AbWS/DGAT, bifunctional WS/DGAT from Acinetobacter baylyi fused with two transmembrane domains from MmWS at the N-terminus; tpMaFAR, MaFAR fused with a transit peptide from AtFAR6 (Aslan ) or a transit peptide (80 amino acid residues) of the small subunit of rubisco complex (Vollheyde ); tpMaFAR::MhWS, fusion of tpMaFAR and MhWS2; tpMaWS, MaWS fused with a transit peptide (80 amino acid residues) of the small subunit of rubisco complex.
Fig. 3.Schematic representation of target pathways for metabolic engineering of wax ester composition. Production of wax esters (WEs) can be engineered in the endoplasmic reticulum [1], or in the plastids by using a chloroplast-localized fatty acyl reductase (tpFAR) and wax synthase (tpWS) or non-plastidial enzymes fused with a transit peptide (tp) [2]. In both cases, selecting FARs and WSs with appropriate substrate specificities (or modifying these) can result in incorporation of the desired fatty acids and alcohols into the final WEs. The composition of the produced WEs can also be tailored by modifying the acyl-ACP [3] or acyl-CoA [4–6] pools, which contain FAR and WS substrates. Knocking out or down-regulating KASII gene, encoding the plastidial enzyme converting 16:0-ACP to 18:0-ACP, increases the 16:0 level in the acyl-ACP pool [3]. Introducing C10 to C14-specific acyl-ACP thioesterases (FatA and FatB), which prematurely terminate plastidial fatty acid synthesis, increases the levels of medium chain fatty acids in the acyl-CoA pool [4]. Higher 18:1-CoA content can be achieved by knocking out or down-regulating genes encoding fatty acid desaturases FAD2 and FAD3 responsible for desaturating 18:1 and 18:2, respectively [5]. Co-expressing a gene encoding the β-ketoacyl-CoA-synthase from the fatty acid elongase complex (FAE) increases the content of very long-chain fatty acyl-CoA (VLCFAs, ≥C20) [6].
|
|
|
|
|
|---|---|---|---|
| Lauryl stearate | 12:0-OH | 18:0 | 12:0–18:0 |
| Cetyl/palmityl gondoate | 16:0-OH | 20:1 | 16:0–20:1 |
| Linoleyl arachidate | 18:2-OH | 20:0 | 18:2–20:0 |
| Linolenyl oleate | 18:3-OH | 18:1 | 18:3–18:1 |
XX:Y indicates a fatty acyl chain with XX carbons and Y unsaturation.
Like other lipids, WEs can be classified according to the length of their acyl-chains. Most common WEs are long-chain WEs, which are composed of C16 and C18 acyl moieties, and very long-chain WEs with >C18 acyl chains. WE containing